Autonomix Medical (AMIX) News Today → Tiny AI projects with huge promise hiding in plain sight … (From Weiss Ratings) (Ad) Free AMIX Stock Alerts $2.44 -0.25 (-9.29%) (As of 11:38 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 4:15 PM | globenewswire.comAutonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell SeriesMay 7, 2024 | marketbeat.comTrading was temporarily halted for "AMIX" at 09:05 AM with a stated reason of "LULD pause."May 5, 2024 | seekingalpha.comAMIX Autonomix Medical, Inc.April 25, 2024 | finance.yahoo.comAutonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary MicrochipApril 24, 2024 | globenewswire.comAutonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment WebinarApril 16, 2024 | globenewswire.comAutonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related PainApril 15, 2024 | finance.yahoo.comAutonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 11, 2024 | benzinga.comAutonomix Medical (NASDAQ: AMIX) Is Cracking the Code Of The Peripheral Nervous System With Its Breakthrough Technology To Treat DiseasesApril 11, 2024 | uk.investing.comAutonomix Medical's study shows promise in renal treatmentApril 9, 2024 | globenewswire.comAutonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal DenervationApril 8, 2024 | globenewswire.comAutonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX TickerMarch 27, 2024 | globenewswire.comAutonomix to Present at the MedInvest Biotech & Pharma Investor ConferenceMarch 21, 2024 | uk.investing.comAutonomix Medical hires new Chief Business OfficerMarch 20, 2024 | globenewswire.comAutonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024March 19, 2024 | globenewswire.comAutonomix Appoints Jennifer Cook as Chief Business OfficerMarch 18, 2024 | marketbeat.comTrading was temporarily halted for "AMIX" at 10:03 AM with a stated reason of "LULD pause."March 18, 2024 | marketbeat.comTrading was temporarily halted for "AMIX" at 09:03 AM with a stated reason of "LULD pause."March 15, 2024 | marketwatch.comAutonomix Medical Shares Rise on First Three Patient Procedures CompletionMarch 14, 2024 | globenewswire.comAutonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer MarketMarch 6, 2024 | globenewswire.comAutonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer MarketMarch 1, 2024 | uk.investing.comAutonomix Medical Inc (AMIX)February 29, 2024 | globenewswire.comAutonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical TrialFebruary 23, 2024 | globenewswire.comAutonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix OpportunityFebruary 22, 2024 | finance.yahoo.comAutonomix Secures Principal Investigators and Completes Clinical Training for First Human StudyFebruary 21, 2024 | morningstar.comAutonomix Medical Inc AMIXFebruary 16, 2024 | globenewswire.comAutonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer MarketFebruary 14, 2024 | globenewswire.comAutonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key MilestonesJanuary 29, 2024 | marketbeat.comTrading was temporarily halted for "AMIX" at 01:01 PM with a stated reason of "LULD pause." Trading set to resume at 01:01 PM. January 29, 2024 | marketbeat.comTrading was temporarily halted for "AMIX" at 10:01 AM with a stated reason of "LULD pause."January 29, 2024 | marketbeat.comTrading was temporarily halted for "AMIX" at 10:01 AM with a stated reason of "LULD pause." Get Autonomix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (Ad)The AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016. Get the full story here. AMIX Media Mentions By Week AMIX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMIX News Sentiment▼1.250.55▲Average Medical News Sentiment AMIX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMIX Articles This Week▼32▲AMIX Articles Average Week Get Autonomix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: InspireMD News Today IceCure Medical News Today Apyx Medical News Today Cytosorbents News Today Monogram Orthopaedics News Today SEP Acquisition News Today Lucid Diagnostics News Today DarioHealth News Today Pro-Dex News Today LENSAR News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMIX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCharles Payne Demystifies OptionsUnstoppable ProsperityTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autonomix Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.